Denmark· DK-28106689221
SOTYKTU
A deucravacitinib product containing deucravacitinib, registered in Denmark by Bristol-Myers Squibb Pharma EEIG. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Deucravacitinib is registered in 12 of 19 countries.
Countries holding a registration under ATC L04AF07 (deucravacitinib), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Deucravacitinib · ATC L04AF07
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of deucravacitinib costs, country by country.
Normalised to the WHO defined daily dose (6 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Deucravacitinib · price per daily dose (6 mg)
USD · FX 28 Sept 2026
- FR France$22.97
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Deucravacitinib
- Manufacturer
- Bristol-Myers Squibb Pharma EEIG
- Country
- Denmark (DK)
- ATC code
- L04AF07
- ATC class
- Deucravacitinib
- Defined daily dose
- 6 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106689221
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L04AF07
Deucravacitinib, as other registers publish it.
- PolandSotyktuBristol-Myers Squibb Pharma EEIG
- NorwaySotyktuBristol-Myers Squibb Pharma EEIG
- FinlandSOTYKTUBristol-Myers Squibb Pharma EEIG
- CzechiaSOTYKTUBristol-Myers Squibb Pharma EEIG, Dublin
- CzechiaSOTYKTUBristol-Myers Squibb Pharma EEIG, Dublin
- CzechiaSOTYKTUBristol-Myers Squibb Pharma EEIG, Dublin
- United StatesSOTYKTUE.R. Squibb & Sons, L.L.C.
- United StatesSOTYKTUE.R. Squibb & Sons, L.L.C.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcb319bb-8b53-4907-b6a2-a525ffe391f5 GET /v1/drugs/bcb319bb-8b53-4907-b6a2-a525ffe391f5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "6 mg",
"auth_role": "MOD",
"dk_drugid": "28106689221",
"substance": "Deucravacitinib",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "45009"
}See everything about deucravacitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.